Skip to main content
Fig. 1 | BMC Clinical Pathology

Fig. 1

From: Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis

Fig. 1

Assessment of protein expression of HER2 and EGFR by IHC staining. (× 400). a, c, Positive expression of HER2 in the primary lesion and ovarian metastases, respectively. b, d, Negative expression of HER2 in primary tumours and ovarian metastases, respectively. e, g, Positive expression of EGFR in primary lesion and ovarian metastases, respectively. f, h, Negative expression of EGFR in primary tumours and ovarian metastases, respectively

Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us